
1. j infect dis. 2011 oct 1;204(7):1120-4. doi: 10.1093/infdis/jir486.

prolonged selection pfmdr1 polymorphisms treatment falciparum malaria
with artemether-lumefantrine uganda.

baliraine fn(1), rosenthal pj.

author information: 
(1)department medicine, university california, san francisco, ca
94143-0811, usa.

comment in
    j infect dis. 2012 may 1;205(9):1473-5; author reply 1475-6.

we compared prevalence key pfmdr1 alleles pretreatment plasmodium 
falciparum parasite isolates parasites emerged treatment of
uncomplicated malaria longitudinal cohort ugandan children. pfmdr1
86n, 184f, 1246d alleles selected treatment with
artemether-lumefantrine, artesunate-amodiaquine or
amodiaquine-sulfadoxine-pyrimethamine. remarkably, selection persisted in
infections presenting 60 days treatment with
artemether-lumefantrine. thus, parasites selected decreased drug sensitivity 
can appear long predicted exposure antimalarial drugs. continued
surveillance clinical efficacy vitro activity new combination
therapies warranted.

doi: 10.1093/infdis/jir486 
pmcid: pmc3164433
pmid: 21881128  [indexed medline]

